Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03488251
Title PK,PD, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Molecular Templates, Inc.
Indications

diffuse large B-cell lymphoma

B-cell lymphoma

Therapies

Gemcitabine + MT-3724 + Oxaliplatin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.